Skip to main content
Ruth Oratz, MD, Oncology, New York, NY, NYU Langone Hospitals

RuthOratzMD

Oncology New York, NY

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology

Clinical Professor of Medicine, NYU School of Medicine

Dr. Oratz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Oratz's full profile

Already have an account?

Summary

  • Dr. Ruth Oratz is an oncologist in New York, NY and is affiliated with NYU Langone Hospitals. She received her medical degree from Albert Einstein College of Medicine and has been in practice 35 years. She also speaks multiple languages, including French. She specializes in breast cancer, cancer genetics/cancer risk assessment.

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1985 - 1988
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 1982 - 1985
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1982

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1983 - 2025
  • CO State Medical License
    CO State Medical License 2003 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2008-2020
  • America's Top Doctors for Cancer Castle Connolly, 2008-2020
  • Top Doctors: New York Metro Area Castle Connolly, 2002, 2008-2020
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Many Women Underestimate Breast Density as a Risk Factor for Breast Cancer, Study Shows
    Many Women Underestimate Breast Density as a Risk Factor for Breast Cancer, Study ShowsJanuary 23rd, 2023
  • Blood Test That Screens for 50 Cancers, Found Promising in Preliminary Study
    Blood Test That Screens for 50 Cancers, Found Promising in Preliminary StudySeptember 13th, 2022
  • To Counter Loneliness, Find Ways to Connect
    To Counter Loneliness, Find Ways to ConnectJune 25th, 2018
  • Join now to see all

Grant Support

  • Interleukin 2 + Histamine Versus Interleukin 2 In Advance Malignant MelanomaNational Center For Research Resources1999–2002
  • Bryostatin 1 (NSC339555) &Cisplatin In Advanced MalignanciesNational Center For Research Resources1999–2002
  • Core--Clinical Research ResourcesNational Cancer Institute1999–2000
  • Core--Patient Research ResourcesNational Cancer Institute1994–1998

Professional Memberships

Other Languages

  • French

Hospital Affiliations